Skip to content

Salivary Minerals in Patients With Peri-implantitis

Analysis of Salivary Minerals Level Variations in Patients With Peri-implantitis

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05897736
Acronym
mineral-perio
Enrollment
25
Registered
2023-06-09
Start date
2023-10-31
Completion date
2026-09-30
Last updated
2023-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periimplant Bone Loss, Periimplant Diseases, Peri-implant Health, Peri-Implantitis and Peri-implant Mucositis, Peri-implant Mucositis

Keywords

salivary minerals, peri-implantitis, peri-implant health, salivary biomarkers

Brief summary

Patients included in the study will be recruited after arriving at the Faculty of Dentistry of the University of Zagreb. During the clinical examination, the patient's periodontal status (bleeding during probing, and the depth of the pockets around the implant) and a control x-ray will be taken to check bone loss. Saliva sampling will occur at 3-time points, when establishing the diagnosis of periimplantitis, before the start of therapy, and at the first control after treatment.

Detailed description

Work protocol Through the Department of Oral Surgery and the Department of Periodontology, patients with symptoms of peri-implantitis are admitted for a planned intervention or radiological diagnostic-therapeutic procedure within the same day. The number of patients planned for inclusion in this research on changes in the level of salivary minerals in peri-implantitis is 25. The treatment of peri-implantitis depends on the clinical symptoms, intra- and post-therapeutic complications are not expected, and a control examination is mandatory. Patient screening Patient selection is based on social and medical criteria. Social criteria - the patient must understand the planned procedure and the postoperative course, agree to the procedure and giving a saliva sample. Medical criteria - at the time of departure for the planned procedure, the patient's health must be in optimally stable condition if the patient suffers from chronic diseases. The main clinical parameters are: 1. presence of plaque, 2. presence of BOP, 3. presence of pus, 4. increased probing depth, 5. loss of alveolar bone. Preparation for the procedure On the day of the examination, the patient comes to the Institute at the agreed time, after which there is a short preparation and, in a pre-established order after a conversation with the researcher, a saliva sample is taken and a dental clinical examination is performed. Before giving a saliva sample, patients should not eat, smoke or brush their teeth for at least 2 hours before. Saliva sampling: Just giving a saliva sample is easy. The patient is placed in a quiet place, the method of spontaneous collection of unstimulated saliva is explained to him. Before the very beginning, he rinses his mouth with plain water, and a 5-minute stopwatch is started during which the patient spits the saliva that is produced in his mouth into a previously weighed polystyrene cup. After 5 minutes, the cup with saliva is placed in the freezer until further biochemical analysis, and the patient is referred for a clinical examination. Biochemical analysis: For the salivary minerals determination, a total of 200 μl of unstimulated saliva sample will be mixed with 40 μl of 5% lanthanum oxide and diluted with deionized water to 2.5 ml for atomic absorption spectrophotometry. Due to the strong affinity of calcium to form complexes with salivary proteins, non-centrifuged whole saliva containing both protein-bound and soluble calcium will be used for the assay. The measurements of salivary calcium will be performed by an atomic absorption spectrophotometer. Clinical examination: the clinical examination will be performed with the help of a graduated periodontal probe. The clinical parameters that will be recorded are: * Plaque index * Bleeding after probing with a plastic probe (BOP) * Supuration, secretion * Probing depth greater than 3 mm * Bone loss visible on X-ray. * Clinical test of stability and mobility. * The presence of swelling and redness of the mucous membrane * foetor ex ore * pain on percussion The treatment of periimplantitis depends on the state of the disease itself. Non-surgical therapy is indicated for peri-implant mucositis, while in the case of further progression of the disease and the appearance of pre-implantitis, non-surgical therapy is only an introduction to treatment, where surgical therapy is the main stage of treatment. For smaller bone defects, the method of choice for treatment is resective surgery, while for larger bone defects, regenerative surgical therapy is indicated. A control examination is usually scheduled after six weeks. If the bleeding has stopped or decreased and if the probing depths (the depth of the pockets around the implant measured with a periodontal probe) have also decreased, the next control is scheduled as needed.

Interventions

None listed

Sponsors

University of Zagreb
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosed peri-implantitis

Exclusion criteria

* uncooperative patient * younger then 18 years old

Design outcomes

Primary

MeasureTime frameDescription
Change in levels of salivary minerals with disease progression/regressionone yearIf it is shown that the minerals of bone metabolism change according to the direction of recovery, it is possible to use salivary minerals (calcium, magnesium and phosphates) as an aid in the prognosis of the course of recovery and reduce the time needed to make a decision on the type and intensity of therapy, as well as the loss itself and implant replacement

Contacts

Primary ContactIvana Sutej
isutej@gmail.com+38598739248
Backup ContactDragana Gabrić
dgabric@sfzg.hr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026